GL1X · GenesisL1 explorer

UniProt P04584

P04584

P04584 (UniProt P04584): 43 experimental structures on GenesisL1, 2 ligands bound. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
P04584
Experimental structures
43
Predicted models
0
Ligands
2

Structures

43 records of P04584 in the MolNFT archive: 43 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
1E0EN-terminal zinc-binding HHCC domain of HIV-2 integrasesolution nmrA, B——
1E0EN-terminal zinc-binding hhcc domain of HIV-2 integrasesolution nmrA, B——
1HIIComparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with cgp…x-ray diffractionA, B——
1HIIComparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with cgp…x-ray diffractionA, B——
1HSHCrystal structure at 1.9 ångströms resolution of human immunodeficiency virus (HIV) II protease…x-ray diffractionA, B, C, D——
1HSHCrystal structure at 1.9 ångströms resolution of human immunodeficiency virus (HIV) II protease…x-ray diffractionA, B, C, D——
1HSICrystal structure at 1.9 ångströms resolution of human immunodeficiency virus (HIV) II protease…x-ray diffractionA, B——
1HSICrystal structure at 1.9 ångströms resolution of human immunodeficiency virus (HIV) II protease…x-ray diffractionA, B——
1IDACrystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine…x-ray diffractionA, B——
1IDACrystal structures of HIV-2 protease in complex with inhibitors containing the hydroxyethylamine…x-ray diffractionA, B——
1IVPThe crystallographic structure of the protease from human immunodeficiency virus type 2 with two…x-ray diffractionA, B——
1IVPThe crystallographic structure of the protease from human immunodeficiency virus type 2 with two…x-ray diffractionA, B——
1IVQThe crystallographic structure of the protease from human immunodeficiency virus type 2 with two…x-ray diffractionA, B——
1IVQThe crystallographic structure of the protease from human immunodeficiency virus type 2 with two…x-ray diffractionA, B——
1JLDPotent HIV protease inhibitors containing a novel (HYDROXYETHYL)AMIDE isosterex-ray diffractionB——
1MU2Crystal structure of HIV-2 reverse transcriptasex-ray diffractionA, B——
1MU2Crystal structure of HIV-2 reverse transcriptasex-ray diffractionA, B——
2HPEComparison of the structures of HIV-2 protease complexes in three crystal space groups with an…x-ray diffractionA, B——
2HPEComparison of the structures of HIV-2 protease complexes in three crystal space groups with an…x-ray diffractionA, B——
2HPFComparison of the structures of HIV-2 protease complexes in three crystal space groups with an…x-ray diffractionA, B——
2HPFComparison of the structures of HIV-2 protease complexes in three crystal space groups with an…x-ray diffractionA, B——
2K4ESolution structure of the HIV-2 UNMYRISTOYLATED MATRIX PROTEINsolution nmrA——
2K4ESolution structure of the HIV-2 unmyristoylated matrix proteinsolution nmrA——
2K4HSolution structure of the HIV-2 myristoylated Matrix proteinsolution nmrA——
2K4HSolution structure of the HIV-2 myristoylated matrix proteinsolution nmrA——
2K4ISolution structure of HIV-2 myrMA bound to di-C4-PI(4,5)P2solution nmrA——
2K4ISolution structure of HIV-2 myrma bound to di-C4-PI(4,5)P2solution nmrA——
2MIPCrystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced…x-ray diffractionA, B, C, D——
2MIPCrystal structure of human immunodeficiency virus (HIV) type 2 protease in complex with a reduced…x-ray diffractionA, B, C, D——
3EBZHigh Resolution HIV-2 Protease Structure in Complex with Clinical Drug Darunavirx-ray diffractionA, B——
3EBZHigh resolution HIV-2 protease structure in complex with clinical drug darunavirx-ray diffractionA, B——
3EC0High Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-06579Ax-ray diffractionA, B——
3EC0High resolution HIV-2 protease structure in complex with antiviral inhibitor grl-06579Ax-ray diffractionA, B——
3ECGHigh Resolution HIV-2 Protease Structure in Complex with Antiviral Inhibitor GRL-98065x-ray diffractionA, B——
3ECGHigh resolution HIV-2 protease structure in complex with antiviral inhibitor grl-98065x-ray diffractionA, B——
3F9KTwo domain fragment of HIV-2 integrase in complex with LEDGF IBDx-ray diffractionA, B, E, F, I, J, M, N, Q, R, U, V, Y, Z, c, d, g, h, k, l, o, p, s, t——
3F9KTwo domain fragment of HIV-2 integrase in complex with ledgf ibdx-ray diffractionA, B, E, F, I, J, M, N, Q, R, U, V, Y, Z, c, d, g, h, k, l, o, p, s, t——
3UPJHuman immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (K57L) complex with…x-ray diffractionA, B——
3UPJHuman immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (K57L) complex with…x-ray diffractionA, B——
4UPJHuman immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (K57L) complex with…x-ray diffractionA, B——
4UPJHuman immunodeficiency virus type 2 protease mutant with lys 57 replaced by leu (K57L) complex with…x-ray diffractionA, B——
5UPJHIV-2 PROTEASE/U99283 complexx-ray diffractionA, BUIN—
6UPJHIV-2 PROTEASE/U99294 complexx-ray diffractionA, BNIU—

Ligands

  • NIU · 6,7,8,9-tetrahydro-4-hydroxy-3-(1-phenylpropyl) cyclohepta[b]pyran-2-one · in 1 record
  • UIN · 5,6,7,8,9,10-hexahydro-4-hydroxy-3-(1-phenylpropyl) cycloocta[b]pyran-2-one · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.